Board Performance · 2025
In this section15 topics
- Compliance Monitoring — Overview1 item
- Prevention of Conflicts of Interest3 items
- Prevention of the Use of Inside Information3 items
- Anti-Corruption4 items
- Whistleblowing3 items
- Selection of Directors & Chief Executives8 items
- Selection of Independent Directors2 items
- Director Development1 item
- Evaluation of Board & Subcommittee Performance3 items
- Subcommittees1 item
- Meeting Attendance & Remuneration5 items
- Supervision of Subsidiaries & Associated Companies5 items
- Board Duty Performance — Overview1 item
- Audit Committee Duty Performance2 items
- Executive Committee Duty Performance1 item
Compliance Monitoring — Overview
Compliance Monitoring — Introduction
The Company emphasizes good corporate governance by establishing policies and related guidelines in its corporate governance policy and business ethics. Additionally, it encourages implementation to build confidence in all stakeholders.
Prevention of Conflicts of Interest
Has the Company Acted to Prevent Conflicts of Interest?
Yes
Operations in the Past Year
The Company has established guidelines for directors, executives, and employees under the Code of Business Conduct, which requires them to report any personal interests and potential conflicts of interest involving themselves or related persons. This is to prevent the misuse of their positions as directors, executives, or employees for personal benefit. The Company has therefore established the following practices:
Directors, executives, and employees must avoid situations where personal interests conflict with the interests of the Company when dealing with business partners or other parties.
During their employment with Eforl-Aim Group, and even after termination of employment, directors, executives, and employees must not disclose any confidential information of the Company to any person. Such confidential information includes electronic data, financial information, operational information, business information, the Company’s future plans, and other related information.
Directors, executives, and employees must not engage in or invest in any business that competes or may compete with the Company’s business. If a family member of a director, executive, or employee becomes involved in or holds a significant shareholding in any business that may create a conflict of interest with the Eforl-Aim Group, the matter must be reported in writing to the Chief Executive Officer or Managing Director as soon as possible.
Directors, executives, and employees should refrain from holding shares with decision-making authority in businesses that compete with the Company if such shareholding may influence them to perform or refrain from performing their duties in the best interest of the Company. In cases where such shares were acquired prior to becoming a director, executive, or employee, before the Company entered such business, or were obtained through inheritance, the individual must report the matter to the Chief Executive Officer or his/her supervisor.
Executives and employees who wish to serve as directors or advisors in other companies, organizations, or business associations must ensure that such positions do not conflict with their duties or the Company’s interests, and must obtain prior approval from the Chief Executive Officer or Managing Director.
Executives and employees must not borrow money from business partners of the Company, except from financial institutions, as this may influence the performance of their duties as representatives of the Company.
Directors, executives, and employees are prohibited from making payments or transferring Company assets to any person without approval from authorized persons in accordance with the Company’s approval authority matrix.
Executives and employees must not use the Company’s working time to perform other work unless necessary and with prior approval from their supervisor. Directors, executives, and employees must perform their duties for the best interests of the Company. In the event that any person has an interest in a transaction under consideration, such person must inform the Secretary of the Audit Committee, and must abstain from participating in the consideration and approval of that transaction.
In 2025, the Company reviewed cases that may give rise to conflicts of interest and did not find any violations of the Company’s conflict of interest policy.
Number of Conflict-of-Interest Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to conflicts of interest (cases) | 0 | 0 | 0 |
Prevention of the Use of Inside Information
Has the Company Acted to Prevent the Use of Inside Information?
Yes
Operations in the Past Year
The Company has established measures to ensure the proper use of inside information in compliance with applicable laws and the principles of good corporate governance. Such measures are set out in writing in the Code of Business Conduct. The key policies are summarized as follows:
Directors, executives, and employees must strictly comply with the regulations of the Securities and Exchange Commission (SEC) and other applicable laws, including the requirement to disclose information to shareholders and/or the public in an equitable manner.
The Company communicates and emphasizes to directors, executives, and employees that the use of undisclosed inside information for personal benefit in trading the Company’s securities constitutes a violation of the Company’s Code of Business Conduct.
Directors, executives, and employees who have access to information relating to the Company’s financial statements are prohibited from buying or selling the Company’s securities during the period of 45 days prior to the disclosure of the financial statements and 24 hours after such disclosure.
For other material information, directors, executives, and employees who are aware of such information are prohibited from trading the Company’s securities from the date they become aware of the information until 24 hours after the information has been disclosed to the Stock Exchange of Thailand (SET).The disclosure of information that may affect the Company’s business operations or share price must be approved by the Chief Executive Officer (CEO). The CEO will either disclose such information directly or assign an appropriate person to be responsible for the disclosure.
The Investor Relations Department is responsible for communicating information to the public and investors, while the relevant departments that own the information are responsible for providing supporting data.
Directors, executives, and employees must not provide opinions or recommendations regarding the trading of the Company’s securities unless such communication is related to their assigned duties within the Company.
These guidelines have been approved by the Board of Directors. All directors and executives acknowledge their obligations to report their securities holdings in the Company, including those held by their spouse and minor children, as well as any changes in such holdings, to the Securities and Exchange Commission (SEC) and the Stock Exchange of Thailand (SET) in accordance with Section 59 and the penalties under Section 275 of the Securities and Exchange Act B.E. 2535 (1992).
In 2025, no directors or executives traded the Company’s securities. The Company’s review confirmed that all relevant parties complied fully with the Company’s policy on the use of inside information.
Number of Inside-Information Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to the use of inside information to seek benefits (cases) | 0 | 0 | 0 |
Anti-Corruption
Has the Company Acted on Anti-Corruption?
Yes
Operations in the Past Year
The Company is committed to preventing and guarding against corruption, both directly and indirectly, to ensure that business operations, which may carry corruption risks, are carefully considered and conducted. The Company has developed an anti-corruption policy as a guideline to operate the business and encourage an organizational culture with honesty and integrity. The Company has a policy to donate to public welfare institutions such as hospitals, public health agencies, and other organizations within the guidelines outlined in the authorization table.
1. Donation Policy: The Company does not have a policy to accept inappropriate donations.
2. Financial Support: Financial support refers to money provided to customers, partners, investors, or other individuals, for business relationships with transparency and reasonability.
3. Receiving Financial Support: The Company does not have a policy of accepting financial support that is deemed unreasonable or unclear.
4. Process and Control of Donation Requests and Financial Support:
- Donation and financial support activities should align with the company's policies.
- Clear objectives should be defined for each donation and financial support provided.
- Specific individuals, units, or organizations should be identified, along with a designated timeframe, for receiving donations or support for various purposes.
- Proper documentation, such as receipts or other evidence of receipt of funds, should be maintained.
- Approval authority should adhere to the Company's regulations, utilizing an "Approval Authority Matrix" for consideration.
5. Offer gift and hospitality: The Company does not engage in offering gifts in any form to individuals involved in business dealings with the company unless it conforms to customary norms and is considered suitable to foster positive relationships, without anticipating specific benefits or favors, which would be unethical by business standards. The provision of gifts and hospitality should adhere to the following guidelines:
1) Must adhere to customary practices, conducted transparently and with integrity.
2) Should be appropriate and commensurate with the occasion.
3) Must comply with all applicable laws, regulations, and the company's ethical standards and policies
6. Receiving Gifts and Hospitality:
1) Gifts valued at more than THB 3,000 must be declined upon receipt. If declining is not feasible, the recipient must report it to the highest authority within the organization using a gift receipt report form or another appropriate document to transfer the gift to the Company’s property. If the gift is in the form of cash, it must be declined under all circumstances.
2) Accepting items for promotional purposes should not imply an agreement for joint business or be for the benefit of any individual. Acceptance is permissible only in cases of inter-company transactions that do not contradict the anti-corruption policy and must be supported by clear documentation that can be verified.
3) Gift and hospitality receiving should adhere to the following criteria
- It conforms to common practice with transparency.
- It will be appropriate in terms of value and duration.
- Must not violate laws, regulations, and must comply with the company's ethics and policies.
7. Receiving discounts from business partners: Receiving discounts from business partners, whether in monetary form or any other assets, must adhere to general business practices and transparency.
8. Investments and trading: The Company has an investment policy that adheres to principles of fair competition..
9. Procurement and Contracting: The Company ensures fair and transparent procurement and contracting practices for all parties involved. Procurement and contracting proposals must be presented to authorized people according to the Company's authority delegation schedule, and must comply with the regulations set by the Company.
10. Financial Accounting:
1) Receiving cash from customers, legal entities, or any other individuals:
- Prior to accepting cash, the finance department must be informed each time regarding the purpose for which the funds are being received and the rationale behind the specified amount.
- The Company shall not request or accept financial benefits or any other advantages from the payer to delay the receipt of funds by the company, or to cause harm to the company due to non-receipt of funds, delayed receipt, or receipt of an incomplete amount.
2) Payment to creditors, legal entities, or any other individuals:
- Prior to each payment, the purpose for which the payment is made must be verified, and it must be accurately recorded by the accounting department in accordance with accounting principles and relevant laws. Any inaccuracies or improprieties discovered should be reported to authorized personnel for appropriate corrective action in alignment with accounting principles and relevant laws.
- Every approval for payment must comply with the schedule of authority delegation.
- Treat creditors or recipients equally by adhering to the appropriate terms and conditions for payment. Avoid engaging in discriminatory or biased practices towards any creditor or recipient.
- Do not demand, accept, offer, or provide any financial or other benefits to creditors or recipients that may cause harm to the Company.
11. Anti-Money Laundering: The Company will comply with Anti-Money Laundering laws.
12. Human Resources Practices: The Company's human resources management includes anti-corruption policies that extend from recruitment and hiring to compensation and benefits administration.
13. Communication, Training, and Disclosure: The Company communicates, provides training, and discloses information internally and externally about policies and implementation for anti-corruption to relevant stakeholders.
14. Recording and Data Retention: The Company adheres to policies in accordance with standards, principles, and applicable laws regarding financial reporting and accounting data, as well as various business data, ensuring compliance with the law.
15. Audit procedure/ internal audit: The Company has established a regular internal audit process, conducted quarterly by the internal audit firm approved by the Stock Exchange of Thailand. The audit procedure and scope of work include independent and unrestricted tasks, covering anti-corruption measures. Additionally, the financial statements are audited by certified auditors quarterly and annually, in accordance with the regulations of the Securities and Exchange Commission, the Department of Business Development, and the Revenue Department. The Company establishes reporting procedures for audit results as follows:
- The internal audit firm must report audit results and identified issues to the audit committee at least once per quarter.
- In case of urgent matters, the internal auditor shall report to the Chairman of the Audit Committee immediately.
- The Audit Committee is responsible for reporting audit results to the Board of Directors.
16. Monitoring and Review: The Company establishes continuous monitoring of compliance with anti-corruption policies through an internal audit process. If issues or increased risks are identified, they will be presented to the audit
Form of Anti-Corruption Operations
| Operation |
|---|
| Communication and training for employees on anti-corruption policy and guidelines |
Number of Corruption Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to corruption (cases) | 0 | 0 | 0 |
Whistleblowing
Has the Company Implemented Whistleblowing Procedures?
Yes
Operations in the Past Year
The Company encourage directors, executives, and employees, as well as stakeholders to involve in overseeing compliance with laws, regulations, principles of good corporate governance, and business ethics. This includes reporting and complaining about illegal activities or unethical behaviors that may indicate corruption or misconduct within the organization. This ensures that business operations are transparent and more effective. Therefore, the Company establishes whistleblowing standards and provides mechanisms to protect whistleblowers and those accused, while also emphasizing the confidentiality of whistleblowing data, which will only be accessible to authorized individuals directly involved. This is done to instil confidence in whistleblowers.
The Company has a channel for stakeholders to whistle blow through the "Complaints and Whistleblowing Box" located at E For L Aim Public Company Limited Office, 432 Ratchawithi Road, Bang Yi Khan Sub-district, Bang Phlat District, Bangkok 10700, which will be considered by the independent audit committee, and the Company's secretariat screens such matters.
In the past year, the Company has not received any complaints or whistle blows related to corruption or violations of the Company's corporate governance policies.
Number of Whistleblowing Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues received through whistleblowing channels (cases) | 0 | 0 | 0 |
Selection of Directors & Chief Executives
Selection, Development & Evaluation — Introduction
The nomination, development, and performance evaluation of directors are carried out by the management team, which is responsible for identifying, screening, and selecting qualified candidates in accordance with the Company’s nomination procedures. The selected candidates are then proposed to the Nomination and Remuneration Committee for further consideration and screening. In this process, the Committee takes into account the appropriateness of the Board in terms of the number of directors, board structure, board composition, and the qualifications of individual directors. The Company does not impose restrictions based on gender, race, religion, or any other differences.
A key principle in the Company’s nomination and selection of directors and senior executives is that candidates must possess the knowledge, expertise, and capabilities that align with the Company’s needs and strategic direction, as well as meet all qualifications required under applicable laws and regulations.
Selection — Introduction
The Company provides shareholders with the opportunity to propose qualified candidates for nomination as directors at least three months prior to the end of the Company’s fiscal year. Such invitation is announced through the news system of the Stock Exchange of Thailand and on the Company’s website.
For the year 2025, no shareholder proposed any candidate for election as a director of the Company.
In addition, the Company considered potential candidates from the Director Pool database of the Thai Institute of Directors Association as part of the nomination process in accordance with the Company’s procedures. In the case of re-appointing existing directors for another term, the Nomination and Remuneration Committee considers the directors’ qualifications, performance, meeting attendance, and contributions to the activities of the Board of Directors. For independent directors, the Committee also takes into account the independence of such directors.
Directors & Chief Executives — Introduction
The Board of Directors comprises individuals with diverse qualifications in various areas of expertise, including industry knowledge, accounting and finance, medical sciences, business strategy, corporate governance, and law. The Board also reflects diversity in terms of gender, education, and age. The Company’s directors possess the knowledge, capabilities, and experience beneficial to the Company’s business operations and do not have any prohibited characteristics under the Public Limited Companies Act.
The Board of Directors includes at least three independent directors, representing not less than one-third of the total number of directors.
Director Nomination
The process for nominating directors is transparent and follows the Company's established procedures. Directors who have completed their term may be reappointed for a new term. Prior to the Annual General Meeting (AGM), the company provides an opportunity for shareholders to propose individuals they believe are qualified to be considered for nomination as directors, as well as to suggest any agenda items.
For the 2025 AGM, the company announced the opportunity for shareholders to propose qualified individuals for director nomination, along with any proposed agenda items, from November 1 2024, to January 31 2025.
However, by the designated deadline, no shareholders had proposed any director nominations or agenda items to the Company. The Nomination and Remuneration Committee is responsible for reviewing and screening the qualifications of directors and sub-committees before presenting them to the Board of Directors. Individuals who are proposed as directors and have received approval from the Board will be included in the meeting agenda for presentation to the shareholders at the Annual General Meeting.
In the event that a director's position becomes vacant for reasons other than the expiration of their term and/or a sub-committee member who is not a director of the Company, except in cases where the remaining term of the director is less than two months, the individual appointed to replace the director will hold the position only for the remaining term of the director being replaced. The Nomination and Remuneration Committee will review and evaluate the qualifications of the proposed replacement and present the recommendation to the Board of Directors for approval to ensure the board's composition remains as required. The individual appointed to replace the director will serve only for the remaining term of the director they are replacing.
The selection of the Board of Directors and sub-committee members is conducted through a resolution passed at the shareholders' meeting, where shareholders vote individually for each nominee. Shareholders cast votes for each individual nominee, using all the votes they hold. Voting for the election of directors will be based on a majority vote. In the event of a tie, the chairman of the meeting will cast the deciding vote.
For the election of a director and/or sub-committee member who is not currently a director of the company, in cases where the position becomes vacant for reasons other than the expiration of their term, the resolution of the Board must be passed by a vote of at least three-fourths of the remaining directors.
Recruitment of the Chief Executive
The Board of Directors has assigned the Nomination and Remuneration Committee the responsibility of establishing the criteria and procedures for selecting a qualified individual for the position of the top management. The committee evaluates potential candidates based on their qualifications, experience, knowledge, and expertise, ensuring they are well-suited to manage the Company’s operations. The committee then submits its recommendations, along with justifications, to the Board of Directors for consideration and appointment, ensuring alignment with the Company’s strategic goals.
The Nomination and Remuneration Committee is tasked with identifying and evaluating candidates for top management positions, including the Chief Executive Officer (CEO). Additionally, the committee is responsible for overseeing the creation and management of a succession plan for top executive roles. This plan is presented to the Board of Directors for approval and is reviewed annually to ensure a smooth transition in leadership.
Are Directors Selected Through the Nomination Committee?
Yes
Are Chief Executives Selected Through the Nomination Committee?
Yes
Number of Directors from Major Shareholders
0
Rights of Minority Shareholders on Director Appointment
Each shareholder has voting rights equal to the number of shares they hold, with one share is being entitled to one vote.
Shareholders may use all their votes to elect one or multiple candidates as directors. However, if voting for multiple candidates, votes cannot be distributed unequally among them. In the voting process, shareholders cast their votes for the appointment of directors on an individual basis, using the ballot that lists the nominated candidates.
Candidates with the highest number of votes will be elected as directors until all available positions are filled. In the event of a tie for the final position(s), the Chairman will cast the deciding vote.
Method of Director Appointment
| Method |
|---|
| Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights |
Selection of Independent Directors
Criteria for Selecting Independent Directors
The Nomination and Compensation Committee is responsible for evaluating the qualifications of individuals proposed by management, who have been nominated through the Company’s selection process. This includes recommendations from board members, shareholder nominations, and the review of director candidates from the Director Pool database of the Thai Institute of Directors Association. The committee carefully selects individuals with the appropriate qualifications and independence, as defined by the Company, in compliance with relevant regulations and requirements. The selected candidates are then proposed to the Board of Directors for appointment or to the shareholders’ meeting for approval, in accordance with the Company’s by laws and applicable laws.
The Nomination and Compensation Committee considers several factors when evaluating potential candidates for the Board of Directors. These include the candidates' qualifications, with no restrictions on gender, age, or ethnicity, as well as their experience, legal history, independence, and alignment with the Company’s strategic direction. Additionally, the committee evaluates the overall composition and structure of the Board using the Board Skill Matrix. This process involves collecting feedback through forms and organizing the data into a Board Skill Matrix table to define the criteria for selecting directors.
In considering the reappointment of incumbent directors for another term, the Nomination and Compensation Committee evaluates several factors, including performance, attendance at meetings, and contributions to the Board's activities. For independent directors, the committee also assesses their independence.
In the event that a director's position becomes vacant for reasons other than the expiration of their term, the Board of Directors has the authority to appoint an individual who meets the qualifications and is not disqualified by law to fill the position. This appointment is made through a Board meeting, unless the remaining term of the director who vacated the position is less than two months. The appointed individual will serve only for the remainder of the term of the director they are replacing. Additionally, the appointment must be approved by a vote of at least three-quarters of the remaining directors.
The Company sets more stringent qualifications for independent directors than the minimum requirements specified by law. For example, independent directors must hold no more than 0.5% of the total voting shares of the Company, including shares held in the parent company, subsidiaries, joint ventures, or any entity that may pose a conflict of interest. This includes shares held by related parties.
Note: You can refer to the Corporate Governance Policy for further details on the qualifications of independent directors.
Did Any Independent Director Have a Business or Professional Relationship?
No
Director Development
Director Development — Introduction
The Board of Directors has a policy to support and encourage the development of knowledge among directors and executives. The company secretary shall facilitate the directors in seminars and training sessions.
Currently, all members of the board (6 people) have participated in director training programs such as the Director Certification Program (DCP) and/or the Director Accreditation Program (DAP) offered by the Institute of Directors (IOD). This represents 100% of the total number of directors.
Evaluation of Board & Subcommittee Performance
Criteria for Evaluating Board Performance
The Company evaluates the performance of the Board of Directors and subcommittees, both individually and collectively. The assessment covers key areas such as board structure and qualifications, roles and responsibilities, relationships with management, meeting participation, duties, and self-development. The purpose of the evaluation is to review performance, identify challenges and obstacles from the past year, and enhance the effectiveness of all board committees. Additionally, it serves as a basis for reviewing and improving board operations over the past year.
Additionally, the Company has a self-assessment process for the CEO (Chief Executive Officer). The Board of Directors has assigned the Nomination and Remuneration Committee to conduct an evaluation of the CEO’s performance at least once a year. The CEO is required to perform a self-assessment and submit the results to the Nomination and Remuneration Committee for review. The committee then provides feedback and presents the results of the evaluation, along with recommendations for setting an appropriate remuneration, to the Board of Directors.
Evaluation of Board Performance in the Past Year
In addition, for the year 2025, the performance evaluations of the Board of Directors and subcommittees, including the Audit Committee, Nomination and Remuneration Committee, Management Committee, and Risk Management Committee, both collectively and individually, have been rated as good level.
Evaluation Results
| Evaluated Body | Group — Carried Out? | Group — Grade / Average Score | Group — Grade / Full Score | Individual (Self-Assessment) — Carried Out? | Individual (Self-Assessment) — Grade / Average Score | Individual (Self-Assessment) — Grade / Full Score | Cross (Assessing Other Directors) — Carried Out? |
|---|---|---|---|---|---|---|---|
| Board Of Director | Y | 3.76 | 4.00 | Y | 3.76 | 4.00 | N |
Subcommittees
Subcommittees
| Results of the Subcommittee's Duty Performance |
|---|
In 2025, the Nomination and Remuneration Committee held two meetings to consider various matters and submitted the meeting results together with its opinions to the Board of Directors for consideration on a continuous basis. The key matters considered are summarized as follows:
|
The Risk Management Subcommittee considers and provides opinions on risk assessment results, risk management approaches, risk mitigation measures, and action plans to manage and prevent the Company’s risks. This is to ensure that the Company has adequate and appropriate risk management processes in place. The Subcommittee also oversees and supports the successful implementation of enterprise risk management, provides recommendations on risk prevention and risk reduction to acceptable levels, and continuously monitors risk mitigation plans in line with the Company’s business conditions to ensure that risks are properly and effectively managed. In 2025, the Risk Management Subcommittee held a total of 11 meetings to continuously monitor the Company’s risk prevention and risk management efforts in three key areas as follows:
In addition, the Subcommittee monitored the results of internal audits relating to the inventory management system, cash control cycle, and petty cash management, in order to recommend improvements to the internal control system in accordance with the internal auditor’s recommendations. This was to ensure that the Company maintains adequate and appropriate risk management. Furthermore, the Subcommittee monitored enterprise risk management by promoting and supporting the continuous improvement and development of the Company’s internal risk management system. The Subcommittee also ensured that the Company’s risk management policy and framework are reviewed at least annually to ensure alignment with the Company’s overall business operations and risk management activities. The Subcommittee regularly reports key organizational risks, risk status, risk mitigation approaches, progress, and risk management outcomes to the Board of Directors for acknowledgement. |
Meeting Attendance & Remuneration
Meeting Attendance — Introduction
Board and subcommittee meetings are scheduled in advance. The Company Secretary or the secretary of each subcommittee distributes meeting invitations together with supporting documents to each director at least seven days prior to the meeting to allow sufficient time for review. The Chairman presides over the meetings, ensuring that each agenda item is given sufficient time for open and independent discussion. Senior executives are encouraged to attend meetings to receive feedback from the Board. Directors with a conflict of interest on any agenda item abstain from both discussions and voting on that matter.
The Board of Directors has established that non-executive directors will meet regularly as appropriate each year. During these meetings, no executive directors will be present, allowing non-executive directors to discuss various issues and matters concerning the company, such as management strategies, growth directions, or other relevant topics of interest.
Justification for Directors' Non-Attendance
Mr. Somchai Treeratnaphitak was absent from the meeting due to illness.
Ms. Watcharaporn Suwinchai was absent from the meeting due to illness and other commitments.
Remuneration — Introduction
The Board of Directors has assigned the Nomination and Remuneration Committee to review the remuneration structure and determine appropriate compensation rates for the Board of Directors and all subcommittees. The proposed remuneration is then submitted to the Board of Directors for approval before being presented at the Annual General Meeting of Shareholders for final approval. The Company follows these policies and criteria in determining remuneration:
- The roles, scope of authority, duties, and responsibilities of the Board of Directors and each subcommittee.
- The Company's performance, considering the type and size of businesses within the same industry, ensuring that the remuneration is competitive, fair, and sufficient to attract and retain qualified directors. The remuneration must align with the responsibilities and duties of the directors.
Types of Remuneration of the Board of Directors
Monthly Remuneration
Board of Directors
Chairman of the Board receives a monthly remuneration of THB 50,000.
Directors receive a monthly remuneration of THB 30,000 per person.
Audit Committee
Chairman of the Audit Committee receives a monthly remuneration of THB 28,000.
Audit Committee Members receive a monthly remuneration of THB 25,000 per person.
Risk Management Subcommittee
Chairman of the Risk Management Subcommittee receives a monthly remuneration of THB 20,000.
Members of the Risk Management Subcommittee, who are not executives or employees of the Company, receive a monthly remuneration of THB 15,000 per person.
Meeting Allowances
Nomination and Remuneration Committee
Chairman of the Nomination and Remuneration Committee receives a meeting allowance of THB 20,000 per meeting.
Members of the Nomination and Remuneration Committee receive a meeting allowance of THB 15,000 per meeting.
Executive Committee
Chairman of the Executive Committee receives a meeting allowance of THB 15,000 per meeting.
Members of the Executive Committee receive a meeting allowance of THB 10,000 per meeting.
Notes
Meeting allowances for the Executive Committee are paid only to members who also serve as directors of the Company.
Meeting allowances are paid only to members who attend the meeting. In the event that a director holds more than one position, he or she is entitled to receive all forms of remuneration, including directors’ remuneration and meeting allowances.
The Annual General Meeting of Shareholders for the year 2025 resolved to authorize the Board of Directors to allocate remuneration for directors and other subcommittees within a total amount not exceeding THB 5,000,000.
Remuneration or Benefits Payable to the Board
| Metric | Amount (Baht) |
|---|---|
| Remunerations or benefits pending payment to the board of directors over the past year (baht) | 1,075,000 |
Supervision of Subsidiaries & Associated Companies
Does the Company Have Subsidiaries or Associated Companies?
Yes
Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?
Yes
Mechanism for Overseeing Management of Subsidiaries
The Company has established a policy for the supervision and management of its subsidiaries by setting business operation guidelines in accordance with the principles of good corporate governance, consistent with those applied by the Company. This is to ensure efficient management and operations. The Company appoints its representatives to serve as directors or executives in subsidiaries or associated companies in proportion to its shareholding or as otherwise agreed. Such representatives must receive approval from the Board of Directors before assuming their positions. They are responsible for determining policies and conducting business operations of the subsidiaries or associated companies in alignment with the Company’s overall policies. In this regard, the Board of Directors considers the qualifications and background of the individuals proposed to serve as directors or executives to ensure their suitability for the nature of the business of each subsidiary or associated company.
The Company requires that management, as well as directors or executives appointed as its representatives in subsidiaries or associated companies, have clearly defined scopes of authority in order to effectively protect the Company’s interests. They are also required to report to management or submit significant matters to the Board of Directors for consideration and approval in accordance with the Company’s policies and applicable laws.
The Company also requires that subsidiaries or associated companies establish regulations governing related party transactions, acquisitions or disposals of assets, and other significant transactions. Such regulations must comply with the Company’s standards as well as the disclosure requirements and relevant rules prescribed by the Stock Exchange of Thailand.
Furthermore, subsidiaries or associated companies are required to implement appropriate internal control systems and monitoring mechanisms, such as appointing external parties to conduct internal audits and report the results, in order to safeguard the assets of the Company and its subsidiaries. In addition, subsidiaries or associated companies must maintain proper records and accounting systems to enable the Company to review information and prepare consolidated financial statements in a timely manner.
Oversight Mechanisms
| Mechanism |
|---|
| Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings |
| Defining the scope of powers, duties and responsibilities of directors and executives who represent the company in setting important policies |
| Disclosure of financial information and operating results |
| Transactions between the Company and related persons |
| Other important transactions |
| Acquisition or disposal of assets |
| Internal control system of the subsidiary operating the core business is appropriate and sufficient in the subsidiary operating the core business |
Agreements Between the Company and Shareholders in Managing Subsidiaries
The Company does not have a Shareholders' Agreement.
Board Duty Performance — Overview
Board Duty Performance — Overall Description
In 2025, the Company held a total of 10 board meetings to fulfill its roles and responsibilities in accordance with the Board Charter. The key activities are summarized as follows:
Reviewed the Company's vision, mission, policies, Board Charter, and charters of subcommittees. Defined business direction and business plans in alignment with the Company's strategies, policies, objectives, regulations, shareholder resolutions, applicable laws, the Stock Exchange of Thailand’s (SET) regulations, and other relevant authorities' requirements.
Approve the business plan, budget, establishment of measures, and practices, and oversee business operations to be conducted under the principles of good corporate governance. Monitor operating performance to meet the planned objectives.
Consider and provide an opinion on the financial report, monitor connected transactions to ensure compliance with relevant regulations. Additionally, establish guidelines for related transactions and connected transactions that are more stringent than SET regulations.
Acknowledged the general report, audit committee report, and subcommittee report. Acknowledged the internal audit report, Company risk management report, and established guidelines for improvement. Also, monitoring the implementation of these improvement guidelines.
Determined to conduct evaluations of the performance of the board of directors and subcommittees, both as groups and individuals. This includes assessing the performance of chief executive officers to utilize the information for improvement.
Audit Committee Duty Performance
Performance Results — Introduction
As of 31 December 2025, the Audit Committee comprised a total of three members, all of whom were independent directors. Mr. Thanadech Mahaphokaikul possesses knowledge and experience in reviewing the Company’s financial statements.
Results of the Audit Committee's Duty Performance in the Past Year
In 2025, the Audit Committee held five meetings with management, the Internal Audit Office, and the external auditors on relevant agenda items. In addition, the Audit Committee held separate meetings with the external auditors without the presence of management.
The Audit Committee regularly reported the results of its meetings to the Board of Directors. The key matters performed and reviewed by the Audit Committee are summarized as follows:
Review of Financial Reports: The Audit Committee reviewed the Company’s quarterly financial information and the annual financial statements for the year 2025, which were prepared in accordance with Thai Financial Reporting Standards (TFRS). The review covered significant matters, including the adequacy of financial information disclosures, accounting policies, and significant accounting estimates. The Committee also considered the observations and recommendations of the external auditors and obtained sufficient explanations from the auditors, management, and relevant parties. The Audit Committee therefore had confidence that the Company’s financial statements were prepared in compliance with applicable laws and generally accepted accounting principles. The disclosures in the notes to the financial statements were considered accurate, adequate, reliable, and beneficial to investors and users of the financial statements.
Review of Internal Control and Internal Audit: The Audit Committee reviewed the internal control assessment results reported by the Internal Audit Office of the Group. The review covered key areas including accounting, finance, fraud prevention, asset safeguarding, operational processes, monitoring procedures, and compliance with applicable laws and regulations. The review results were consistent with the opinion of the external auditors, who reported no material weaknesses in the internal control system. The Internal Audit Office operates independently and focuses on preventive auditing to effectively identify and manage potential risks. The Company also provides full cooperation with the Internal Audit Office in monitoring new key issues in a timely manner in order to safeguard the interests of shareholders and stakeholders effectively.
Good Corporate Governance: The Audit Committee reviewed the Company’s compliance with the Code of Business Ethics and encouraged the Company to conduct its business with integrity, transparency, and in accordance with good corporate governance principles. The Committee also monitored the implementation of the Whistleblowing Policy, ensuring that employees were informed of the reporting procedures. A whistleblowing channel was provided through a confidential message box, allowing employees to report misconduct directly to the Chairman of the Audit Committee. The Secretary of the Audit Committee was responsible for forwarding such reports to the Chairman while ensuring the confidentiality and protection of whistleblowers.
Review of Related Party Transactions or Potential Conflicts of Interest: The Audit Committee placed importance on reviewing related party transactions and transactions that may involve conflicts of interest. Clear written guidelines for related party transactions were established to ensure transparency in operational procedures. The Committee reviewed transactions between the Company, its subsidiaries, and related parties to ensure that such transactions were conducted under normal business conditions, were reasonable, and were in the best interests of the Company. These transactions were also reviewed to ensure compliance with the relevant laws and regulations of the Stock Exchange of Thailand (SET) and the Securities and Exchange Commission (SEC).
Risk Management Oversight: The Audit Committee reviewed the Company’s enterprise risk management framework and risk management plans, particularly focusing on significant risks such as foreign exchange risk. The Company has implemented policies to mitigate such risks through foreign currency forward contracts and appropriate accounting treatment for goods in transit from overseas in accordance with applicable accounting standards.
In addition, during 2025, the Audit Committee reviewed and monitored the Company’s internal control systems in three operational areas, namely: the Information Technology General Controls (IT General Controls Review), the warehouse security management system, and the revenue and billing cycle (Sales, Service Revenues and Collections). In addition, the Audit Committee assigned the internal auditor to review and monitor the inventory management cycle (Warehousing and Inventory Management) as well as the cash control and advance payment management cycle (Cash Controls and Management and Advance Payment Control). The review was conducted through inquiries with management and examination of supporting documents from relevant departments. The Committee also followed up on management’s corrective actions in response to recommendations from internal auditors to ensure continuous improvement of internal controls. This process supported the Company’s risk management oversight and enabled the identification of emerging risks in response to changes in the Company’s operations and the medical equipment and healthcare services industry. The Committee also encouraged the use of both internal and external data for risk analysis to support timely and effective decision-making.
Consideration of the Appointment of External Auditors and Audit Fees for 2025: The Audit Committee considered the selection of external auditors based on the Company’s evaluation criteria, including independence, professional competence, quality of work, auditing standards, and qualifications in accordance with the requirements of the Stock Exchange of Thailand.
The Audit Committee proposed the appointment of the following auditors from BDO Audit Company Limited to the Board of Directors for further approval by the shareholders:
1. Mr. Teerasak Chuasrisakul, Certified Public Accountant No. 6624, or
2. Mr. Kraisaeng Thiranulak, Certified Public Accountant No. 5428, or
3. Mr. Narin Churamongkol, Certified Public Accountant No. 8593, or
4. Ms. Supachanya Thongpan, Certified Public Accountant No. 10505, or
5. Ms. Amornjid Baolorpet, Certified Public Accountant No. 10853
as the Company’s external auditors for the year 2025, with an audit fee of THB 2,100,000. The audit fees for the annual and quarterly financial statements of the subsidiaries totaled THB 550,000, resulting in a combined audit fee for the Company and its subsidiaries of THB 2,650,000.
The Audit Committee performed its duties as assigned with independence, due care, and prudence, while ensuring fair treatment for all stakeholders. The Company has adhered to good corporate governance practices and maintained an appropriate risk management framework, as well as effective internal control and internal audit systems capable of responding to changes arising from both internal and external factors.
The Company has also complied with applicable laws and regulations relating to its business operations. The financial statements for the year ended 31 December 2025 were prepared accurately and reliably, with adequate disclosure of information.
Executive Committee Duty Performance
Results of the Executive Committee's Duty Performance in the Past Year
In 2025, the Executive Committee held a total of 11 meetings to consider various matters within the framework assigned by the Board of Directors. The Committee consistently reported its findings and/or presented proposals to the Board of Directors for consideration and feedback. The key activities are summarized as follows:
Policy and Planning: Reviewed and formulated policies, goals, strategies, annual business plans, and budgets. This included reviewing the delegation of authority and the Executive Committee Charter before seeking approval from the Board of Directors.
Monitoring and Supervision: Monitored and evaluated the performance of the Company and its subsidiaries. This ensured that business operations remained aligned with the policies, goals, strategies, operational plans, and annual budgets approved by the Board of Directors.
Financial Transactions and Advisory: Considered and approved financial transactions with financial institutions—including account openings, borrowings, pledges, guarantees, and other related activities—to ensure efficient operations within the authorized limits. Additionally, the Committee provided guidance and advice on management to senior executives.
The Executive Committee has consistently reported its meeting resolutions and operational results to the Board of Directors.

